Bhushan Dravyakar

1.1k total citations
10 papers, 878 citations indexed

About

Bhushan Dravyakar is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Bhushan Dravyakar has authored 10 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 5 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Bhushan Dravyakar's work include Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Quinazolinone synthesis and applications (2 papers). Bhushan Dravyakar is often cited by papers focused on Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Quinazolinone synthesis and applications (2 papers). Bhushan Dravyakar collaborates with scholars based in India. Bhushan Dravyakar's co-authors include Atul P. Sherje, Mrunal Jadhav, Vasanti Suvarna, Tabassum Khan, Kavitkumar Patel, Manikanta Murahari, Usha Y. Nayak, Pritesh Bhat, Vasanti Suvarna and Pramila Chaubey and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Pharmaceutics and European Journal of Medicinal Chemistry.

In The Last Decade

Bhushan Dravyakar

10 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhushan Dravyakar India 6 370 201 200 151 138 10 878
Maryam Iman Iran 17 353 1.0× 264 1.3× 332 1.7× 99 0.7× 161 1.2× 78 1.1k
Imdad Ali Pakistan 20 252 0.7× 199 1.0× 237 1.2× 246 1.6× 210 1.5× 86 1.1k
Arijit Gandhi India 9 219 0.6× 221 1.1× 155 0.8× 153 1.0× 163 1.2× 14 888
Vilasrao J. Kadam India 13 289 0.8× 449 2.2× 183 0.9× 271 1.8× 263 1.9× 68 1.2k
Ayman Y. Waddad South Africa 15 415 1.1× 437 2.2× 147 0.7× 281 1.9× 289 2.1× 22 1.1k
Subrata Jana India 19 257 0.7× 172 0.9× 325 1.6× 107 0.7× 153 1.1× 66 1.2k
Suhair Sunoqrot Jordan 21 368 1.0× 361 1.8× 143 0.7× 339 2.2× 193 1.4× 53 1.3k
Meihua Han China 20 482 1.3× 432 2.1× 107 0.5× 201 1.3× 288 2.1× 83 1.3k
Sunita Patel India 18 286 0.8× 253 1.3× 122 0.6× 80 0.5× 222 1.6× 48 924

Countries citing papers authored by Bhushan Dravyakar

Since Specialization
Citations

This map shows the geographic impact of Bhushan Dravyakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhushan Dravyakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhushan Dravyakar more than expected).

Fields of papers citing papers by Bhushan Dravyakar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhushan Dravyakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhushan Dravyakar. The network helps show where Bhushan Dravyakar may publish in the future.

Co-authorship network of co-authors of Bhushan Dravyakar

This figure shows the co-authorship network connecting the top 25 collaborators of Bhushan Dravyakar. A scholar is included among the top collaborators of Bhushan Dravyakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhushan Dravyakar. Bhushan Dravyakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dravyakar, Bhushan, et al.. (2018). Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II Inhibitor. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 18(1). 4–25. 5 indexed citations
2.
Patel, Kavitkumar, et al.. (2018). Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis. European Journal of Medicinal Chemistry. 157. 783–790. 26 indexed citations
3.
Khan, Tabassum, et al.. (2018). DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy. 103. 923–938. 181 indexed citations
4.
Suvarna, Vasanti, Pramila Chaubey, Tabassum Khan, et al.. (2018). Bone Health and Natural Products- An Insight. Frontiers in Pharmacology. 9. 981–981. 62 indexed citations
5.
Sherje, Atul P., et al.. (2018). Dendrimers: A versatile nanocarrier for drug delivery and targeting. International Journal of Pharmaceutics. 548(1). 707–720. 252 indexed citations
6.
Sherje, Atul P., et al.. (2017). Cyclodextrin-based nanosponges: A critical review. Carbohydrate Polymers. 173. 37–49. 270 indexed citations
7.
Sherje, Atul P., Manikanta Murahari, Usha Y. Nayak, et al.. (2017). Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Molecular Pharmaceutics. 14(4). 1231–1242. 70 indexed citations
8.
Dravyakar, Bhushan, et al.. (2013). A NOVEL APPROACH TOWARDS DEVELOPMENT OF QUINAZOLINE DERIVATIVES IN PAIN MANAGEMENT. Asian Journal of Pharmaceutical and Clinical Research. 6(7). 200–204. 3 indexed citations
9.
Dravyakar, Bhushan, et al.. (2009). ChemInform Abstract: Design and Syntheses of Some New Diphenylaminoisoxazolines as Potent Antiinflammatory Agent.. ChemInform. 40(7). 4 indexed citations
10.
Dravyakar, Bhushan, et al.. (2008). Design and syntheses of some new diphenylaminoisoxazolines as potent anti-inflammatory agent. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 47(10). 1559–1567. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026